Filing Details
- Accession Number:
- 0001127602-21-015655
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-06 13:00:00
- Reporting Period:
- 2021-05-04
- Accepted Time:
- 2021-05-06 13:21:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1650274 | Ross David Smith | 251 Ballardvale Street Wilmington MA 01887 | Corporate Executive Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-04 | 3,305 | $144.67 | 18,167 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-05-04 | 3,305 | $340.01 | 14,862 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2021-05-04 | 3,305 | $0.00 | 3,305 | $144.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,609 | 2020-02-22 | 2024-02-22 | No | 4 | M | Direct |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.